...

首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >A COST-UTILITY ANALYSIS OF THE RISK MODEL-GUIDED ANTIEMETIC PROPHYLAXIS VERSUS PHYSICIAN'S CHOICE IN PATIENTS RECEIVING CHEMOTHERAPY FOR EARLY-STAGE BREAST CANCER: A NET-BENEFIT REGRESSION APPROACH

【24h】

A COST-UTILITY ANALYSIS OF THE RISK MODEL-GUIDED ANTIEMETIC PROPHYLAXIS VERSUS PHYSICIAN'S CHOICE IN PATIENTS RECEIVING CHEMOTHERAPY FOR EARLY-STAGE BREAST CANCER: A NET-BENEFIT REGRESSION APPROACH

机译：接受早期乳腺癌化疗的患者中风险模型指导的抗药性脯酸对医师选择的成本效用分析：净收益回归方法

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research》 |2016年第7期|共1页
作者
Thavorn K.; Vandermeer L.; Mazzarello S.; Wang Z.; Clemons M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学;
关键词

相似文献

外文文献
中文文献
专利

1. A COST-UTILITY ANALYSIS OF THE RISK MODEL-GUIDED ANTIEMETIC PROPHYLAXIS VERSUS PHYSICIAN'S CHOICE IN PATIENTS RECEIVING CHEMOTHERAPY FOR EARLY-STAGE BREAST CANCER: A NET-BENEFIT REGRESSION APPROACH [J] . Thavorn K., Vandermeer L., Mazzarello S., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：接受早期乳腺癌化疗的患者中风险模型指导的抗药性脯酸对医师选择的成本效用分析：净收益回归方法
2. Impact of initiating antiemetic prophylaxis with palonosetron versus ondansetron on risk of uncontrolled chemotherapy-induced nausea and vomiting in patients with lung cancer receiving multi-day chemotherapy [J] . Bruce Feinberg, James Gilmore, Sally Haislip, Supportive Care in Cancer . 2012,第3期

机译：帕洛诺司琼与昂丹司琼联合开始止吐预防对接受多日化疗的肺癌患者化疗不受控制的恶心和呕吐风险的影响
3. Impact of initiating antiemetic prophylaxis with palonosetron versus ondansetron on risk of uncontrolled chemotherapy-induced nausea and vomiting in patients with lung cancer receiving multi-day chemotherapy [J] . FeinbergB., GilmoreJ., HaislipS., Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer . 2012,第3期

机译：帕洛诺司琼与昂丹司琼联合开始止吐预防对接受多日化疗的肺癌患者化疗不受控制的恶心和呕吐风险的影响
4. A side-effects mapping model in patients with lung, colorectal and breast cancer receiving chemotherapy [C] . Mazzocco Thomas, Hussain Amir 2011 IEEE 13th International Conference on e-Health Networking, Applications and Services . 2011

机译：肺癌，结直肠癌和乳腺癌患者接受化疗的副作用映射模型
5. Effects of primary prophylaxis of neutropenia on outcomes, utilization and expenditures for elderly breast cancer patients receiving chemotherapy. [D] . Rajan, Suja S. 2009

机译：一级预防中性粒细胞减少对老年接受化疗的乳腺癌患者的结局，利用和支出的影响。
6. Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related chemotherapy-related and genetic risk factors [O] . Alena M Pfeil, Christof Vulsteke, Robert Paridaens, 2014

机译：接受化疗的早期乳腺癌患者发热性中性粒细胞减少症发生的多变量回归分析评估患者相关化疗相关和遗传危险因素
7. A Cost-Utility Analysis of the Risk Model-Guided Antiemetic Prophylaxis Versus Physician's Choice in Patients Receiving Chemotherapy for Early-Stage Breast Cancer: A Net-Benefit Regression Approach [O] . K Thavorn, L Vandermeer, S Mazzarello, 2016

机译：风险模型引导止吐预防预防预防患者的成本实用性分析与早期乳腺癌接受化疗的患者：净利润回归方法

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号